LYKOZ THERAPEUTICS

EUIPO EUIPO 2024 Application withdrawn

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark LYKOZ THERAPEUTICS was filed as Word mark on 06/28/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".

Trademark Details Last update: October 15, 2024

Trademark form Word mark
File reference 019047736
Application date June 28, 2024

Trademark owner

1 Lincoln Street, 31st Floor
02111 Boston
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury
42 Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals

Trademark history

Date Document number Area Entry
July 1, 2024 Transfer / Change of address, Registered

ID: 11019047736